Metraipolis › archive › dc_2af5aa85bfb1
Innovating shorter, all-oral, precise, individualized treatment regimen for rifampicin-resistant tuberculosis (INSPIRE TB): study protocol for a pragmatic… — Europe PMC PMID:41845289
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41845289
- DOI
- 10.1186/s12879-[numero omesso]-y
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T08:12:23.010Z
- SHA-256 of the archived text
072e680b122cad627e6118bd5a5d857c614200f06e49c0d5427481d35fe48089- Stable URL of this page
https://metraipolis.com/documento/dc_2af5aa85bfb1
How to cite
Innovating shorter, all-oral, precise, individualized treatment regimen for rifampicin-resistant tuberculosis (INSPIRE TB): study protocol for a pragmatic… — Europe PMC PMID:41845289 — Europe PMC (en), https://europepmc.org/article/MED/41845289 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2af5aa85bfb1 (Metraipolis archive dc_2af5aa85bfb1, sha256 072e680b122cad627e6118bd5a5d857c614200f06e49c0d5427481d35fe48089)
BibTeX
@misc{dc2af5aa85bfb1,
title = {Innovating shorter, all-oral, precise, individualized treatment regimen for rifampicin-resistant tuberculosis (INSPIRE TB): study protocol for a pragmatic… — Europe PMC PMID:41845289},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41845289},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2af5aa85bfb1; sha256 072e680b122cad627e6118bd5a5d857c614200f06e49c0d5427481d35fe48089},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41845289. Agents can read the archived copy with the MCP tool read_document.